Clin2
NCT07162896Likely a fitNot yet recruiting

Comparing two creams for children with mild to moderate eczema

Atopic DermatitisAtopic Dermatitis (AD)

Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.

This study compares two creams for treating mild to moderate eczema in children: crisaborole 2% and tacrolimus 0.1%. It aims to see which one is more effective and safe for your child.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
66 people
Ages
2 years to 18 years
Study type
Interventional

Who can take part

  • Your child must be between 2 and 18 years old.
  • Your child must have mild to moderate atopic dermatitis (eczema).
  • Eczema must cover less than 30% of your child's body.
  • No active skin infection (viral, bacterial, or fungal) at the treatment site.
  • No use of topical steroids, calcineurin inhibitors, PDE4 inhibitors, or immunosuppressive medications in the past 2 weeks.
  • No other chronic inflammatory skin conditions like psoriasis or seborrheic dermatitis that could interfere with the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07519174Not yet recruiting
Comparing two creams for mild to moderate eczema

This study compares two prescription creams, tacrolimus and crisaborole, to see which works better and is safer for treating mild to moderate eczema over 8 weeks. Both creams are applied to the skin and are alternatives to steroids.

Rawalpindi, Punjab Province
NCT07437534Not yet recruiting· Phase 4
Comparing two creams for mild to moderate eczema

This study compares two prescription creams used to treat mild to moderate eczema (atopic dermatitis) in people aged 2 and older. The goal is to see which cream is safer and works better for reducing symptoms like itching and redness.

Peshawar, KPK
NCT07438509Not yet recruiting· Phase 4
Crisaborole cream for mild to moderate eczema

This study tests a new cream called crisaborole to see if it helps with mild to moderate eczema. You would apply the cream twice a day for four weeks.

NCT07358000Recruiting
Comparing two moisturizers for mild to moderate eczema

This trial tests if two different moisturizing balms work equally well for treating mild to moderate eczema (atopic dermatitis) in children and adults. It may help find a more affordable or better-tolerated option.

Caen, Normandy
NCT06756438Recruiting
Cream for eczema in children – test of gentle skin care

This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.

Gdansk, Poméranie
NCT07701447Not yet recruiting
Probiotic ointment for children with eczema

This study tests a new ointment containing probiotics (good bacteria) to see if it helps with eczema in children. It is a cream that is applied to the skin, and the goal is to see if it reduces the itching and redness.

Hear when a new Atopic Dermatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.